Journal Article
A. V. Ivachtchenko, Lavrovsky, Y., and Okun, I.,
“AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.”,
J Alzheimers Dis, vol. 53, no. 2, pp. 583-620, 2016.
A. V. Ivachtchenko, Okun, I., Aladinskiy, V., Ivanenkov, Y., Koryakova, A., Karapetyan, R., Mitkin, O., Salimov, R., and Ivashchenko, A.,
“AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”,
J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
A. Tsugawa, Sakurai, S., Inagawa, Y., Hirose, D., Kaneko, Y., Ogawa, Y., Serisawa, S., Takenoshita, N., Sakurai, H., Kanetaka, H., Hirao, K., and Shimizu, S.,
“Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease.”,
J Alzheimers Dis, vol. 77, no. 2, pp. 539-541, 2020.
G. Cebers, Alexander, R. C., Haeberlein, S. Budd, Han, D., Goldwater, R., Ereshefsky, L., Olsson, T., Ye, N., Rosen, L., Russell, M., Maltby, J., Eketjäll, S., and Kugler, A. R.,
“AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 3, pp. 1039-1053, 2017.
L. Ordoñez-Gutierrez, Fernandez-Perez, I., Herrera, J. Luis, Anton, M., Benito-Cuesta, I., and Wandosell, F.,
“AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 645-56, 2016.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Sacco, S., Carfi, A., Benejam, B., Vermeiren, Y., Beugelsdijk, G., Schippers, M., Hassefras, L., Eleveld, J., Grefelman, S., Fopma, R., Bomer-Veenboer, M., Boti, M., G Oosterling, D. E., Scholten, E., Tollenaere, M., Checkley, L., Strydom, A., Van Goethem, G., Onder, G., Blesa, R., Eulenburg, C. Zu, Coppus, A. M. W., Rebillat, A. - S., Fortea, J., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Sacco, S., Carfi, A., Benejam, B., Vermeiren, Y., Beugelsdijk, G., Schippers, M., Hassefras, L., Eleveld, J., Grefelman, S., Fopma, R., Bomer-Veenboer, M., Boti, M., G Oosterling, D. E., Scholten, E., Tollenaere, M., Checkley, L., Strydom, A., Van Goethem, G., Onder, G., Blesa, R., Eulenburg, C. Zu, Coppus, A. M. W., Rebillat, A. - S., Fortea, J., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
M. G. Cavuoto, Ong, B., Pike, K. E., Nicholas, C. L., Bei, B., and Kinsella, G. J.,
“Better Objective Sleep Quality in Older Adults with High Subjective Memory Decline.”,
J Alzheimers Dis, vol. 53, no. 3, pp. 943-53, 2016.
K. Ohno, Abdelhamid, M., Zhou, C., Jung, C. - G., and Michikawa, M.,
“Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice.”,
J Alzheimers Dis, vol. 89, no. 4, pp. 1413-1425, 2022.
C. Pappas, Small, B. J., Andel, R., Laczó, J., Pařízková, M., Ondrej, L., and Hort, J.,
“Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment.”,
J Alzheimers Dis, 2018.
J. Olazarán, Gil-de-Gómez, L., Rodríguez-Martín, A., Valentí-Soler, M., Frades-Payo, B., Marín-Muñoz, J., Antúnez, C., Frank-García, A., Jiménez, C. Acedo, Gracia, L. Morlén, Torregrossa, R. Petidier, Guisasola, M. Concepció, Bermejo-Pareja, F., Sánchez-Ferro, Á., Pérez-Martínez, D. A., Palomo, S. Manzano, Farquhar, R., Rábano, A., and Calero, M.,
“A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”,
J Alzheimers Dis, 2015.
D. L. Ebel, Torkilsen, C. G., and Ostrowski, T. D.,
“Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1197-1211, 2017.
L. Smith, Shin, J. Il, Oh, H., Carmichael, C., Jacob, L., Stefanac, S., Lindsay, R. K., Soysal, P., Veronese, N., Tully, M. A., Butler, L., Barnett, Y., and Koyanagi, A.,
“Body Mass Index and Mild Cognitive Impairment Among Middle-Aged and Older Adults from Low- and Middle-Income Countries.”,
J Alzheimers Dis, vol. 85, no. 3, pp. 1095-1105, 2021.
C. M Selles, Oliveira, M. M., and Ferreira, S. T.,
“Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S313-S327, 2018.
F. P. M. Oliveira, Moreira, A. Paula, de Mendonça, A., Verdelho, A., Xavier, C., Barroca, D., Rio, J., Cardoso, E., Cruz, Â., Abrunhosa, A., and Castelo-Branco, M.,
“Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?”,
J Alzheimers Dis, vol. 65, no. 1, pp. 89-97, 2018.
K. J. Edmunds, Driscoll, I., Hagen, E. W., Barnet, J. H., Ravelo, L. A., Plante, D. T., Gaitán, J. M., Lose, S. R., Motovylyak, A., Bendlin, B. B., Okonkwo, O. C., and Peppard, P. E.,
“Cardiorespiratory Fitness Attenuates the Deleterious Effects of Sleep Apnea on Cerebral Structure and Perfusion in the Wisconsin Sleep Cohort Study.”,
J Alzheimers Dis, vol. 95, no. 2, pp. 427-435, 2023.
P. Chan, Saleem, M., Herrmann, N., Mielke, M. M., Haughey, N. J., Oh, P. I., Kiss, A., and Lanctôt, K. L.,
“Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1235-1246, 2018.
M. Noguchi-Shinohara, Komatsu, J., Samuraki, M., Matsunari, I., Ikeda, T., Sakai, K., Hamaguchi, T., Ono, K., Nakamura, H., and Yamada, M.,
“Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 3, pp. 905-913, 2017.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H.,
“Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.”,
J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
E. Niemantsverdriet, Ottoy, J., Somers, C., De Roeck, E., Struyfs, H., Soetewey, F., Verhaeghe, J., Van den Bossche, T., Van Mossevelde, S., Goeman, J., De Deyn, P. Paul, Mariën, P., Versijpt, J., Sleegers, K., Van Broeckhoven, C., Wyffels, L., Albert, A., Ceyssens, S., Stroobants, S., Staelens, S., Bjerke, M., and Engelborghs, S.,
“The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.”,
J Alzheimers Dis, vol. 60, no. 2, pp. 561-576, 2017.
C. Gervaise-Henry, Watfa, G., Albuisson, E., Kolodziej, A., Dousset, B., Olivier, J. - L., Jonveaux, T. Rivasseau, and Malaplate-Armand, C.,
“Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting.”,
J Alzheimers Dis, vol. 57, no. 2, pp. 437-445, 2017.
C. B. Malpas, Saling, M. M., Velakoulis, D., Desmond, P., Hicks, R. J., Zetterberg, H., Blennow, K., and O'Brien, T. J.,
“Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.”,
J Alzheimers Dis, vol. 62, no. 1, pp. 417-427, 2018.
S. Abu-Rumeileh, Mometto, N., Bartoletti-Stella, A., Polischi, B., Oppi, F., Poda, R., Stanzani-Maserati, M., Cortelli, P., Liguori, R., Capellari, S., and Parchi, P.,
“Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 551-563, 2018.
] Year 